Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Hedge fund seeder IMQubator says existing investment management model broken, seeks Eur100m for IMQ Fund

Monday, October 24, 2011

Jeroen Tielman, founder of IMQubator
Opalesque Industry Update - Jeroen Tielman, CEO and Founder of IMQubator (“IMQ”), says that the existing investment management model is broken, and is determined to take complaints from hedge fund investors in the wake of the crisis to heart, by demanding the structure and governance of the funds IMQ incubates to be better aligned with the long term interests of investors.

Tielman believes it is time for a new generation of hedge funds – as well as for hedge fund seeders - that can deliver transparency and a consistent investment strategy delivering absolute returns and not fall foul of industry ‘bad habits’.

Capitalised in January 2009 with €250mm from APG, the asset manager for Dutch pensions giant Stichting Pensioenfonds ABP, Amsterdam-based IMQ is leading the way for a new generation of investment managers.

Established by Jeroen Tielman, now a 25-year veteran of the global institutional industry, IMQ offers an institutional platform where professional investors can gain exposure to emerging managers through the IMQubator multi-manager fund.

IMQ has pioneered the process of ‘incubation’, which requires each and every one of the fund managers backed by IMQ to relocate to the firm’s Amsterdam base. They not only share a headquarters, but the same floor. Portfolio managers bump into one another in the corridor and converse over coffee. Advice, support, guidance and, not least, close monitoring, are all at hand. This is a greatly enhanced role in comparison with the standard seeding model performed by more run-of-the-mill competitors.

IMQ has backed its eighth fund (enclosed are more details), IStar Systematic, with €25m of incubation capital. The fund is run by Rudolph Shally and Thomas Artarit, who previously worked together at AIG Financial Products in Tokyo and London.

IMQ has also announced that it - with the endorsement of APG - will raise up to €100 million in fresh capital for the IMQ Fund. The new capital will be used mainly to provide acceleration capital to funds seeded by IMQ. The terms for IMQ investors are designed to be exceptionally attractive; with the purpose of creating an opportunity for them to become potential long-term partners in future offerings. As well as an equity co-investment, investors will be offered a seat on the investment committee, further aligning the interests of the end-investor.

Jeroen Tielman, comments: “IMQubator aims to deliver the emerging manager premium, while providing investors with more power to demand transparency and better alignment in a crisis situation. IMQ is the most cost efficient incubator, offering investors a diversified multi-strategy platform within single manager total fees.

We are in partnership with our clients, with our own savings invested alongside those of our clients. We are seeking to generate absolute returns whilst minimising risk, because this is what our clients want. There has not been enough transparency in the hedge fund management industry, on costs, on performance or investment processes. IMQ will offer full transparency to clients and full accountability.” Corporate website: Source

- FG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner